Several brokerages have updated their recommendations and price targets on shares of Roche Holding (VTX: ROG) in the last few weeks:

  • 6/13/2017 – Roche Holding was given a new CHF 305 price target on by analysts at Barclays PLC. They now have a “buy” rating on the stock.
  • 6/7/2017 – Roche Holding had its “buy” rating reaffirmed by analysts at J P Morgan Chase & Co.
  • 6/6/2017 – Roche Holding was given a new CHF 231 price target on by analysts at Kepler Capital Markets. They now have a “neutral” rating on the stock.
  • 6/6/2017 – Roche Holding was given a new CHF 273 price target on by analysts at Deutsche Bank AG. They now have a “buy” rating on the stock.
  • 6/6/2017 – Roche Holding was given a new CHF 215 price target on by analysts at HSBC Holdings plc. They now have a “sell” rating on the stock.
  • 6/6/2017 – Roche Holding was given a new CHF 335 price target on by analysts at Goldman Sachs Group, Inc. (The). They now have a “buy” rating on the stock.
  • 5/29/2017 – Roche Holding was given a new CHF 305 price target on by analysts at Jefferies Group LLC. They now have a “buy” rating on the stock.
  • 5/29/2017 – Roche Holding was given a new CHF 290 price target on by analysts at Morgan Stanley. They now have a “buy” rating on the stock.
  • 5/26/2017 – Roche Holding was given a new CHF 335 price target on by analysts at Goldman Sachs Group, Inc. (The). They now have a “buy” rating on the stock.
  • 5/20/2017 – Roche Holding was given a new CHF 305 price target on by analysts at Jefferies Group LLC. They now have a “buy” rating on the stock.
  • 5/20/2017 – Roche Holding was given a new CHF 290 price target on by analysts at Morgan Stanley. They now have a “buy” rating on the stock.
  • 5/20/2017 – Roche Holding had its “buy” rating reaffirmed by analysts at J P Morgan Chase & Co.
  • 5/20/2017 – Roche Holding was given a new CHF 335 price target on by analysts at Goldman Sachs Group, Inc. (The). They now have a “buy” rating on the stock.
  • 5/20/2017 – Roche Holding was given a new CHF 320 price target on by analysts at Barclays PLC. They now have a “buy” rating on the stock.
  • 4/18/2017 – Roche Holding had its “buy” rating reaffirmed by analysts at J P Morgan Chase & Co.

Shares of Roche Holding Ltd. (VTX ROG) traded down 0.24% on Wednesday, reaching CHK 250.10. 1,711,996 shares of the company traded hands. Roche Holding Ltd. has a one year low of CHK 218.30 and a one year high of CHK 273.00. The stock has a market capitalization of CHK 213.08 billion and a P/E ratio of 22.00. The stock’s 50 day moving average price is CHK 263.02 and its 200-day moving average price is CHK 247.75.

Roche Holding AG (Roche) is a research-based healthcare company. The Company’s operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics.

Receive News & Ratings for Roche Holding Ltd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche Holding Ltd and related companies with MarketBeat.com's FREE daily email newsletter.